The Evolving Role of ctDNA to Detect Minimal Residual Disease: Implications for the Management of Colorectal Cancer (Enduring)
Discuss the evolving role of circulating tumor DNA in the management of colorectal cancer.
Learning Objectives
Enhance knowledge of the role of ctDNA to Detect Minimal Residual Disease
Available Credit
- 1.00 ACPE - Pharmacist
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 ANCC
- 0.00 Attendance
- 1.00 JA Credit - AH
- 1.00 Approved for AMA PRA Category 1 Credit(s)™